These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

741 related articles for article (PubMed ID: 21843610)

  • 21. Peptide-mediated protein delivery-which pathways are penetrable?
    Räägel H; Säälik P; Pooga M
    Biochim Biophys Acta; 2010 Dec; 1798(12):2240-8. PubMed ID: 20170627
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quantifying molecular partition of cell-penetrating peptide-cargo supramolecular complexes into lipid membranes: optimizing peptide-based drug delivery systems.
    Freire JM; Veiga AS; de la Torre BG; Andreu D; Castanho MA
    J Pept Sci; 2013 Apr; 19(4):182-9. PubMed ID: 23322613
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Arginine-rich cell-penetrating peptides deliver gene into living human cells.
    Liu BR; Lin MD; Chiang HJ; Lee HJ
    Gene; 2012 Aug; 505(1):37-45. PubMed ID: 22669044
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A novel method for monitoring the cytosolic delivery of peptide cargo.
    Cheung JC; Kim Chiaw P; Deber CM; Bear CE
    J Control Release; 2009 Jul; 137(1):2-7. PubMed ID: 19285529
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cell transduction pathways of transportans.
    Padari K; Säälik P; Hansen M; Koppel K; Raid R; Langel U; Pooga M
    Bioconjug Chem; 2005; 16(6):1399-410. PubMed ID: 16287236
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Peptide vectors for the nonviral delivery of nucleic acids.
    Hoyer J; Neundorf I
    Acc Chem Res; 2012 Jul; 45(7):1048-56. PubMed ID: 22455499
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cell-penetrating peptides (CPPs) as a vector for the delivery of siRNAs into cells.
    Nakase I; Tanaka G; Futaki S
    Mol Biosyst; 2013 May; 9(5):855-61. PubMed ID: 23306408
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The uptake of arginine-rich cell-penetrating peptides: putting the puzzle together.
    Brock R
    Bioconjug Chem; 2014 May; 25(5):863-8. PubMed ID: 24679171
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Contributions of glycosaminoglycan binding and clustering to the biological uptake of the nonamphipathic cell-penetrating peptide WR9.
    Ziegler A; Seelig J
    Biochemistry; 2011 May; 50(21):4650-64. PubMed ID: 21491915
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transduction of peptides and proteins into live cells by cell penetrating peptides.
    Mussbach F; Franke M; Zoch A; Schaefer B; Reissmann S
    J Cell Biochem; 2011 Dec; 112(12):3824-33. PubMed ID: 21826709
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Arginine-rich peptides and their internalization mechanisms.
    Futaki S; Nakase I; Tadokoro A; Takeuchi T; Jones AT
    Biochem Soc Trans; 2007 Aug; 35(Pt 4):784-7. PubMed ID: 17635148
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluating the translocation properties of a new nuclear targeted penetrating peptide using two fluorescent markers.
    Zhang R; Yang XZ; Wang JW; Fu LY; Zhao J; Wang FJ
    J Drug Target; 2015 Jun; 23(5):444-52. PubMed ID: 25609361
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chances and pitfalls of cell penetrating peptides for cellular drug delivery.
    Tréhin R; Merkle HP
    Eur J Pharm Biopharm; 2004 Sep; 58(2):209-23. PubMed ID: 15296950
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Stability of cell-penetrating peptide-morpholino oligomer conjugates in human serum and in cells.
    Youngblood DS; Hatlevig SA; Hassinger JN; Iversen PL; Moulton HM
    Bioconjug Chem; 2007; 18(1):50-60. PubMed ID: 17226957
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cell surface clustering of heparan sulfate proteoglycans by amphipathic cell-penetrating peptides does not contribute to uptake.
    Verdurmen WP; Wallbrecher R; Schmidt S; Eilander J; Bovee-Geurts P; Fanghänel S; Bürck J; Wadhwani P; Ulrich AS; Brock R
    J Control Release; 2013 Aug; 170(1):83-91. PubMed ID: 23669260
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of the attachment of a penetration accelerating sequence and the influence of hydrophobicity on octaarginine-mediated intracellular delivery.
    Takayama K; Hirose H; Tanaka G; Pujals S; Katayama S; Nakase I; Futaki S
    Mol Pharm; 2012 May; 9(5):1222-30. PubMed ID: 22486588
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Live-cell analysis of cell penetration ability and toxicity of oligo-arginines.
    Tünnemann G; Ter-Avetisyan G; Martin RM; Stöckl M; Herrmann A; Cardoso MC
    J Pept Sci; 2008 Apr; 14(4):469-76. PubMed ID: 18069724
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Membrane permeation of arginine-rich cell-penetrating peptides independent of transmembrane potential as a function of lipid composition and membrane fluidity.
    Wallbrecher R; Ackels T; Olea RA; Klein MJ; Caillon L; Schiller J; Bovée-Geurts PH; van Kuppevelt TH; Ulrich AS; Spehr M; Adjobo-Hermans MJW; Brock R
    J Control Release; 2017 Jun; 256():68-78. PubMed ID: 28411183
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Internalization of nucleoside phosphates into live cells by complex formation with different CPPs and JBS-nucleoducin.
    Mussbach F; Pietrucha R; Schaefer B; Reissmann S
    Methods Mol Biol; 2011; 683():375-89. PubMed ID: 21053144
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genetic, cellular, and structural characterization of the membrane potential-dependent cell-penetrating peptide translocation pore.
    Trofimenko E; Grasso G; Heulot M; Chevalier N; Deriu MA; Dubuis G; Arribat Y; Serulla M; Michel S; Vantomme G; Ory F; Dam LC; Puyal J; Amati F; Lüthi A; Danani A; Widmann C
    Elife; 2021 Oct; 10():. PubMed ID: 34713805
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 38.